BOTOX
Showing 1 - 25 of 767
Masseter Muscle Prominence Trial (BOTOX, Placebo for BOTOX)
Not yet recruiting
- Masseter Muscle Prominence
- BOTOX
- Placebo for BOTOX
- (no location specified)
Nov 14, 2023
Excessive Gingival Display Trial (procedure, device, drug)
Not yet recruiting
- Excessive Gingival Display
- Botox injection
- +2 more
- (no location specified)
Oct 3, 2023
BPH, Intravesical Botox, ThuLEP Trial (Thulium Laser Enucleation of the Prostate (ThuLEP), Intravesical Botox injection)
Not yet recruiting
- BPH
- +4 more
- Thulium Laser Enucleation of the Prostate (ThuLEP)
- Intravesical Botox injection
- (no location specified)
Jun 11, 2023
BOTOX, Percutaneous Tibial Nerve Stimulation Trial in Benha (drug, procedure, combination product)
Not yet recruiting
- BOTOX
- Percutaneous Tibial Nerve Stimulation
- Solifenacin group
- +3 more
-
Benha, Qalyubiyya, EgyptPediatric Urology departments Benha University Hospitals
Jun 17, 2023
COPD Trial in Webster (OnabotulinumtoxinA, Placebo)
Not yet recruiting
- COPD
- OnabotulinumtoxinA
- Placebo
-
Webster, TexasTranquil Clinical Research
Aug 17, 2023
Overactive Bladder Syndrome Trial run by the Walter Reed National Military Medical Center (Xeomin 100 UNT Injection, Botox 100
Recruiting
- Overactive Bladder Syndrome
- Xeomin 100 UNT Injection
- Botox 100 UNT Injection
-
Bethesda, MarylandWalter Reed National Military Medical Center
Sep 5, 2023
Drug-resistant Focal Seizure Trial (OnabotulinumtoxinA 145 UNT [Botox])
Not yet recruiting
- Drug-resistant Focal Seizure
- OnabotulinumtoxinA 145 UNT [Botox]
- (no location specified)
Oct 31, 2022
Masseter Muscle Prominence Trial in Coatbridge (BOTOX, Placebo)
Recruiting
- Masseter Muscle Prominence
- BOTOX
- Placebo
-
Coatbridge, United KingdomWaverley Medical Practice /ID# 246432
Oct 11, 2023
Glabellar Lines Trial (Botulinum Toxin Type A Injection [HG102], Botulinum Toxin Type A Injection [Botox])
Not yet recruiting
- Glabellar Lines
- Botulinum Toxin Type A Injection [HG102]
- Botulinum Toxin Type A Injection [Botox]
- (no location specified)
Apr 5, 2023
Excessive Gingival Display Trial (botox prior to modified lip repostioning)
Not yet recruiting
- Excessive Gingival Display
- botox prior to modified lip repostioning
- (no location specified)
Nov 20, 2023
Myofascial Trigger Point Pain, Myofascial Pain Syndrome Trial in Cairo (Acupuncture needle, Dry needle, Botox Injectable
Recruiting
- Myofascial Trigger Point Pain
- Myofascial Pain Syndrome
- Acupuncture needle
- +2 more
-
Cairo, EgyptWajma Sayed Karim Al Sayed
Aug 22, 2023
Myofacial Pain Trial in Fayoum (intraoral trigger point injection by botox, transcutaneous trigger point injection by botox)
Enrolling by invitation
- Myofacial Pain
- intraoral trigger point injection by botox
- transcutaneous trigger point injection by botox
-
Fayoum, EgyptFayoum University
Jan 7, 2023
Erectile Dysfunction Trial in Cairo (Injection of Botulinum neurotoxin (BoNT), Penile duplex and shear wave elastosonography
Recruiting
- Erectile Dysfunction
- Injection of Botulinum neurotoxin (BoNT)
- Penile duplex and shear wave elastosonography (SWE).
-
Cairo, EgyptFaculty of Medicine, Cairo University
Sep 19, 2023
Orthognathic Relapse Trial (Botox)
Not yet recruiting
- Orthognathic Relapse
- Botox
- (no location specified)
Oct 8, 2022
Compartment Syndrome of Leg Trial in Madison (Botox)
Recruiting
- Compartment Syndrome of Leg
- Botox
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Dec 6, 2022
Chronic Migraine Trial in Jacksonville (IncobotulinumtoxinA (XEOMIN®), OnabotulinumtoxinA (BOTOX®))
Not yet recruiting
- Chronic Migraine
- IncobotulinumtoxinA (XEOMIN®)
- OnabotulinumtoxinA (BOTOX®)
-
Jacksonville, North CarolinaNaval Medical Center Camp Lejeune
Oct 25, 2022
Spasmodic Dysphonia Trial (Zinc gluconate supplement, Botulinum toxin type A)
Not yet recruiting
- Spasmodic Dysphonia
- Zinc gluconate supplement
- Botulinum toxin type A
- (no location specified)
Jun 6, 2023
Urinary Bladder, Overactive, Urodynamics, Effect of Drug Trial in Taipei (Intradetrusor Botox® (onabotulinumtoxinA) injection,
Recruiting
- Urinary Bladder, Overactive
- +2 more
- Intradetrusor Botox® (onabotulinumtoxinA) injection
- Combine Mirabegron and Solifenacin.
-
Taipei, TaiwanMackay Memorial Hospital
Jul 29, 2023
Achalasia Trial in Nashville (drug, device, other, diagnostic test)
Enrolling by invitation
- Achalasia
- Botulinum toxin type A
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center Endoscopy Laboratory
May 2, 2022
Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin, Zinc Supplementation for Botulinum Toxin Treatment of the Forehead,
Not yet recruiting
- Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin
- +4 more
- zinc citrate 50 mg
- Placebo Microcrystalline Cellulose
- (no location specified)
May 30, 2023
Benign Prostatic Hyperplasia, Overactive Bladder Trial in Cleveland, Lyndhurst, Richmond Heights (Intravesical Botox injection)
Suspended
- Benign Prostatic Hyperplasia
- Overactive Bladder
- Intravesical Botox injection
-
Cleveland, Ohio
- +2 more
Dec 16, 2022
Glabellar Frown Lines Trial (PROTOXIN, Botox®)
Not yet recruiting
- Glabellar Frown Lines
- PROTOXIN
- Botox®
- (no location specified)
Aug 16, 2022
Overactive Bladder Trial in Houston (Intradetrusor Botox Injections)
Recruiting
- Overactive Bladder
- Intradetrusor Botox Injections
-
Houston, TexasHouston Methodist Hospital
Dec 14, 2022
Oily Skin Trial in Montreal (Botox Cosmetic)
Active, not recruiting
- Oily Skin
- Botox Cosmetic
-
Montreal, Quebec, CanadaErevna Innovations Inc
May 10, 2022
Ventral Hernia, Abdominal Hernia Trial in United States (BOTOX Dose A, Placebo for BOTOX, BOTOX Dose B)
Not yet recruiting
- Ventral Hernia
- Abdominal Hernia
- BOTOX Dose A
- +3 more
-
Loma Linda, California
- +5 more
Nov 4, 2022